Figure 3
From: Stem cell factor SALL4, a potential prognostic marker for myelodysplastic syndromes
SALL4 expression was correlated with cytogenetic characters. SALL4 expression in MDS patients with high-risk karyotypes was significantly higher than patients with intermediate and low karyotypes, however there was no significant difference between patients with intermediate and low karyotypes. The risk classification of karyotypes was based on IPSS. ***P-value<0.001, ns: no significance. The lines indicate mean value of each group.